DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

1.03 0.04 (4.05%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LXRX $1.03 4.05%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.99
Previous Close $0.99
Daily Range $0.97 - $1.03
52-Week Range $0.80 - $1.82
Market Cap $746.9M
P/E Ratio -5.21
Dividend (Yield) $0.00 (0.0%)
Volume 2,396,182
Average Daily Volume 2,556,660
Current FY EPS -$0.19

Sector

Healthcare

Industry

Drug Makers

Lexicon Pharmaceuticals, Inc. (LXRX) Description

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Website: http://www.lexpharma.com/

News & Commentary

7 States Where Diabetes Prevalence Is the Highest

More than 29 million people now have diabetes, but its occurrence is the highest within these seven U.S. states.

Health Care Sector Update for 04/15/2015: LXRX,BMY,CLSN,AKBA

Health Care Sector Update for 04/15/2015: LXRX, GLMD, NAVB

Jefferies: 10 Buyout Targets To Own During The M&A Boom

Lexicon Pharmaceuticals (LXRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tap

Lexicon Pharmaceuticals (LXRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape

Lexicon Pharmaceuticals - A Diamond In The Rough?

Lexicon-Ipsen Agreement Expanded to Include Canada - Analyst Blog

8 Analyst Stocks Under $10 With Massive Upside Calls

Health Care Sector Update for 03/09/2015: LXRX, HTBX, CTIC

Lexicon Pharma Announces Closing of Enrollment in Pivotal Phase 3 Clinical Trial of Telotristat Etip

Lexicon Pharma Announces Closing of Enrollment in Pivotal Phase 3 Clinical Trial of Telotristat Etiprate

Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q4 2014 Results - Earnings Call Transcript

See More LXRX News...

LXRX's Top Competitors

LXRX $1.03 (4.05%)
Current stock: LXRX
AMGN $163.58 (-1.97%)
Current stock: AMGN
GILD $101.38 (-1.90%)
Current stock: GILD
BIIB $419.44 (-2.15%)
Current stock: BIIB